目前分子生物学研究方法已广泛应用于各种疾病的研究。象脑血管病这样临床较复杂的疾病 ,通过分子生物学的研究方法也取得了新的进展。近年来 ,组织型纤溶酶原激活剂 (ｔ-ＰＡ)的研究和开发 ,给溶栓治疗开辟了一条新的途径。研究证明脑血管病与遗传性因素有关 ,一般来说 ,遗传 The current molecular biology research methods have been widely used in various diseases. Newer advances have also been made in molecular biology research, as are the more clinically complex diseases such as cerebrovascular disease. In recent years, the research and development of tissue-type plasminogen activator (t-PA) has opened up a new way for thrombolytic therapy. Studies have shown that cerebrovascular disease and genetic factors, in general, genetic